Header

UZH-Logo

Maintenance Infos

Corneal collagen cross-linking (CXL) for the treatment of melting keratitis in cats and dogs: a pilot study


Spiess, B M; Pot, S A; Florin, M; Hafezi, F (2014). Corneal collagen cross-linking (CXL) for the treatment of melting keratitis in cats and dogs: a pilot study. Veterinary Ophthalmology, 17(1):1-11.

Abstract

Objective UV-A/riboflavin cross-linking (CXL) of corneal collagen fibers is an estab- lished, highly promising therapy for corneal melting in physician-based ophthalmol- ogy. A prospective pilot study was conducted to demonstrate proof of principle of this novel method for the treatment of melting corneal ulcers in dogs and cats.
Procedures After obtaining owner consent, CXL was performed in three cats and three dogs with corneal melting, which either affected the entire corneal surface or was resistant to conventional antibiotic and anticollagenolytic therapy, or affected parts or all of the corneal surface. Medical therapy was continued in all patients. The available follow-up ranged from 2 to 22.5 months and involved slit-lamp examination, fluores- cein staining, and photographic documentation during all rechecks.
Results Surgical stabilization of the cornea was not necessary in any case, because pro- gression of corneal melting was arrested in all cases within 1–20 days of CXL treat- ment. Corneal re-epithelization occurred within 7–40 days in all eyes. At 40 days after CXL, all eyes presented a quiescent corneal state without signs of active inflammation and with beginning scar formation. The complications observed in three of the six animals included a corneal sequestrum, superficial corneal stromal pigmentation, and bullous keratopathy.
Conclusions This study shows the feasibility of CXL to treat progressive corneal melting in veterinary patients. CXL may represent a cost-efficient and safe alternative therapy in the treatment for corneal melting in veterinary ophthalmology. More inves- tigations comparing the effectivity and complication rate of CXL to those of standard medical treatment are necessary.

Abstract

Objective UV-A/riboflavin cross-linking (CXL) of corneal collagen fibers is an estab- lished, highly promising therapy for corneal melting in physician-based ophthalmol- ogy. A prospective pilot study was conducted to demonstrate proof of principle of this novel method for the treatment of melting corneal ulcers in dogs and cats.
Procedures After obtaining owner consent, CXL was performed in three cats and three dogs with corneal melting, which either affected the entire corneal surface or was resistant to conventional antibiotic and anticollagenolytic therapy, or affected parts or all of the corneal surface. Medical therapy was continued in all patients. The available follow-up ranged from 2 to 22.5 months and involved slit-lamp examination, fluores- cein staining, and photographic documentation during all rechecks.
Results Surgical stabilization of the cornea was not necessary in any case, because pro- gression of corneal melting was arrested in all cases within 1–20 days of CXL treat- ment. Corneal re-epithelization occurred within 7–40 days in all eyes. At 40 days after CXL, all eyes presented a quiescent corneal state without signs of active inflammation and with beginning scar formation. The complications observed in three of the six animals included a corneal sequestrum, superficial corneal stromal pigmentation, and bullous keratopathy.
Conclusions This study shows the feasibility of CXL to treat progressive corneal melting in veterinary patients. CXL may represent a cost-efficient and safe alternative therapy in the treatment for corneal melting in veterinary ophthalmology. More inves- tigations comparing the effectivity and complication rate of CXL to those of standard medical treatment are necessary.

Statistics

Citations

12 citations in Web of Science®
11 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

155 downloads since deposited on 22 Mar 2013
12 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:05 Vetsuisse Faculty > Veterinary Clinic > Equine Department
Dewey Decimal Classification:570 Life sciences; biology
630 Agriculture
Language:German
Date:9 January 2014
Deposited On:22 Mar 2013 12:26
Last Modified:07 Dec 2017 19:19
Publisher:Wiley-Blackwell
ISSN:1463-5216
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1111/vop.12027

Download

Download PDF  'Corneal collagen cross-linking (CXL) for the treatment of melting keratitis in cats and dogs: a pilot study'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 575kB
View at publisher